MPH Health Care AG (0W1Q), a Berlin-based listed investment holding company focused on healthcare equity stakes, has successfully completed an accelerated bookbuilding placement of 927,755 existing shares in its core holding, M1 Kliniken AG, with institutional investors. The shares were placed at EUR 17.50 each, generating gross proceeds of approximately EUR 16 million for MPH. The transaction, announced and completed on 19 November 2026, reduces MPH's stake in M1 Kliniken from approximately 66 per cent to approximately 61 per cent, though MPH retains a clear majority position. Investors will be watching whether the expanded free float attracts a broader institutional shareholder base in M1 Kliniken.

Key Points

  • MPH Health Care AG (0W1Q), ISIN DE000A289V03, listed on Regulated Unofficial Markets including Frankfurt and Tradegate
  • 927,755 existing M1 Kliniken AG shares placed via accelerated bookbuilding at EUR 17.50 per share
  • Gross proceeds of approximately EUR 16 million; trade date 20 November 2026, settlement date 24 November 2026
  • MPH retains approximately 61 per cent of M1 Kliniken; a three-month lock-up applies to remaining shares

MPH Health Care Sells 5% of M1 Kliniken via Accelerated Bookbuilding at EUR 17.50

MPH Health Care AG, headquartered at Grünauer Straße 5 in Berlin, completed the accelerated bookbuilding on 19 November 2026, placing 927,755 existing shares in M1 Kliniken AG — representing approximately 5 per cent of M1's issued share capital — with institutional investors. The placement price was fixed at EUR 17.50 per share, resulting in gross proceeds to MPH of approximately EUR 16 million. Cantor acted as Sole Global Coordinator and Sole Bookrunner for the transaction. The placed shares carry full dividend entitlement for the financial year 2026, the announcement states.

MPH Remains M1 Kliniken's Majority Shareholder After Settlement on 24 November 2026

Following settlement, which is expected on 24 November 2026, MPH's shareholding in M1 Kliniken AG will decrease from approximately 66 per cent to approximately 61 per cent. The company confirmed it remains the majority shareholder and described M1 Kliniken as its strategic core holding. CEO Patrick Brenske stated in the announcement that the placement increases M1's free float and creates conditions for a broader institutional shareholder base, while MPH's continued majority stake underlines its long-term commitment to M1's development.

Three-Month Lock-Up on Remaining M1 Kliniken Shares Limits Near-Term Disposal Activity

A three-month lock-up period applies to MPH's remaining M1 Kliniken shares following the placement, subject to customary exceptions, according to the announcement. This restriction limits MPH's ability to conduct further disposals in the short term, a factor investors may consider when assessing the company's near-term capital allocation flexibility. MPH Health Care AG describes its broader investment strategy as focused on long-term value creation within growth segments of the healthcare market, with M1 Kliniken representing its primary strategic asset.

MPH Health Care AG's Investment Holding Model and Healthcare Sector Focus

MPH Health Care AG operates as a listed investment holding company, generating value through equity stakes in healthcare businesses rather than direct clinical operations. Its stated focus is on growth segments of the healthcare market, with M1 Kliniken AG as its dominant holding. The accelerated bookbuilding structure used in this transaction is designed to execute share placements rapidly with pre-identified institutional buyers, reducing market risk during the placement window. The company is listed across multiple German trading venues including Frankfurt's Basic Board, Munich, Stuttgart, Dusseldorf, and Tradegate.